Increased mRNA expression of ADAMTS metalloproteinases in metastatic foci of head and neck cancer

Head and Neck

Volumn 31, Issue 6, 2009, Pages 793-801

  Demircan, Kadir ^a   Gunduz, Esra ^a   Gunduz, Mehmet ^a,b   Beder, Levent Bekir ^b   Hirohata, Satoshi ^a   Nagatsuka, Hitoshi ^a   Cengiz, Beyhan ^a   Cilek, Mehmet Zeynel ^a   Yamanaka, Noboru ^b   Shimizu, Kenji ^a   Ninomiya, Yoshifumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS; Aggrecanases; Angiogenesis; HNSCC; Metastasis; Tumor suppressor

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; PROTEIN ADAMTS 1; PROTEIN ADAMTS 15; PROTEIN ADAMTS 4; PROTEIN ADAMTS 5; PROTEIN ADAMTS 8; PROTEIN ADAMTS 9; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADAM PROTEINS; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67049118205     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21045     Document Type: Article

References (24)

1. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63. (Pubitemid 38114082)
2. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2005;25: 9-34. (Pubitemid 43723979)
3. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272: 556-562. (Pubitemid 27021194)
4. Porter S, Span PN, Sweep FC, et al. ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer 2006;118:1241-1247. (Pubitemid 43185612)
5. Gunduz M, Nagatsuka H, Demircan K, et al. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005;356:109-117. (Pubitemid 41175976)
6. Kuno K, Okada Y, Kawashima H, et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000;478:241-245. (Pubitemid 30621625)
7. Collins-Racie LA, Flannery CR, Zeng W, et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004;23:219-230. (Pubitemid 39013980)
8. Held-Feindt J, Paredes EB, Blömer U, et al. Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer 2006;118:55-61. (Pubitemid 41681580)
9. Demircan K, Hirohata S, Nishida K, et al. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 2005;52: 1451-1460. (Pubitemid 40663937)
10. Vankemmelbeke MN, Jones GC, Fowles C, et al. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 2003;270:2394-2403. (Pubitemid 36645357)
11. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 2006;25:2452-2467.
12. Vázquez F, Hastings G, Ortega MA, et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999;274:23349-23357. (Pubitemid 129529172)
13. Dunn JR, Panutsopulos D, Shaw MW, et al. METH-2 silencing and promoter hypermethylation in NSCLC. Br J Cancer 2004;96:1149-1154. (Pubitemid 39336255)
14. Porter S, Scott SD, Sassoon EM, et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 2004;10: 2429-2440. (Pubitemid 38445703)
15. Dunn JR, Reed JE, du Plessis DG, et al. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 2006;94:1186-1193.
16. Rocks N, Paulissen G, Qusada-Calvo F, et al. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer 2006;94:724-730. (Pubitemid 43361905)
17. Masui T, Hosotani R, Tsuji S, et al. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 2001;7:3437-3443. (Pubitemid 33069978)
18. Rocks N, Paulissen G, El Hour M, et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008;90:369-379. (Pubitemid 351172571)
19. Somerville RP, Longpre JM, Jungers KA, et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003;278:9503-9513. (Pubitemid 36800443)
20. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954-958,960,962. (Pubitemid 28275129)
21. Lo PH, Leung AC, Kwok CY, et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 2007;26:148-157. (Pubitemid 46067340)
22. Miyoshi T, Hirohata S, Ogawa H, et al. Tumor-specific expression of the RGD-alpha3 (IV) NC1 domain suppresses endothelial tube formation and tumor growth in mice. FASEB J 2006;20:1904-1906. (Pubitemid 44933774)
23. Cross NA, Chandrasekharan S, Jokonya N, et al. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate 2005; 63:269-275. (Pubitemid 40571061)
24. Yamazaki S, Iwamoto R, Saeki K, et al. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 2003;163:469-475. (Pubitemid 37429861)